Alexander BioDiscoveries is a biopharmaceutical company committed to the discovery and development of novel drugs to treat viral infections, such as seasonal, avian (H5N1) and swine (H1N1) influenza. Based on technology developed by University of Virginia personnel the company is developing lead compounds for the treatment of seasonal influenza. The compounds are prototypes of a new class of anti-virals known as NS-1 inhibitors, which are designed to prevent the influenza virus from interfering with the bodys immune system.
